Author(s)

Hanni Zhang¹, Yunliang Guo¹, Keli Ge^1*, Yanan Wang^1,2*

¹The Center for Integrated Traditional Chinese and Western Medicine, Department of Medicine, Qingdao University, Qingdao, China.
²The Affiliated Hospital of Qingdao University, Qingdao, China.

Gastric cancer represents a major cause of cancer-related death worldwide. Although various tactics and anti-tumor drugs have been used to improve curative effects, five-year survival rate of lung cancer patients remains poor. Evodiamine, a sophora alkaloid, has been demonstrated to exert antitumor effects on many types of cancer. However, the molecular mechanism of evodiamine against gastric cancer has not been clearly elucidated. In this study, we investigated the anti-tumor activity and the underlying mechanisms of EVO on gastric cancer cells, and found that it significantly inhibited the proliferation of BGC-823 and SGC-7901 cells by inducing cell cycle arrest at G2/M phase and cell apoptosis in a dose- and time-dependent manner. Its molecular mechanism may be that it reduces the expression of cell cycle- promoting protein Cdc25C and promotes the expression of cell cycle inhibitor p53, as well as prompts the activity of caspases pathways, such as the expression level of cleaved caspase-3 and cleaved caspase-8; cleaved caspase-9 and cleaved PARP-1 are up-regulated, treated with EVO (10 μM) at different points in time (0, 3, 6, 9, 12, 24 h). Collectively, our data demonstrated that EVO was a potential anti-tumor agent against gastric cancer.

Evodiamine (EVO), BGC-823 Cells, SGC-7901 Cells, Proliferation, Cell Cycle, Cell Apoptosis

Zhang, H. , Guo, Y. , Ge, K. and Wang, Y. (2019) Evodiamine Inhibits the Proliferation of BGC-823 and SGC-7901 Cells by Inducing Cell Cycle Arrest and Apoptosis in Gastric Cancer. Open Access Library Journal, 6, 1-12. doi: 10.4236/oalib.1105217.